DK543488A - Midler til stimulering af et pattedyrs immunreaktion over for gnrh samt et modificeret gnrh og en vaccine til inhibering af et pattedyrs reproduktionsevne - Google Patents

Midler til stimulering af et pattedyrs immunreaktion over for gnrh samt et modificeret gnrh og en vaccine til inhibering af et pattedyrs reproduktionsevne

Info

Publication number
DK543488A
DK543488A DK543488A DK543488A DK543488A DK 543488 A DK543488 A DK 543488A DK 543488 A DK543488 A DK 543488A DK 543488 A DK543488 A DK 543488A DK 543488 A DK543488 A DK 543488A
Authority
DK
Denmark
Prior art keywords
mammal
gnrh
stimulating
vaccine
inhibit
Prior art date
Application number
DK543488A
Other languages
English (en)
Other versions
DK543488D0 (da
Inventor
David W Silversides
Bruce D Murphy
Reuben J Mapletoft
Vikram Misra
Anne Francis Allen
Original Assignee
Univ Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan
Publication of DK543488D0 publication Critical patent/DK543488D0/da
Publication of DK543488A publication Critical patent/DK543488A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK543488A 1987-09-30 1988-09-29 Midler til stimulering af et pattedyrs immunreaktion over for gnrh samt et modificeret gnrh og en vaccine til inhibering af et pattedyrs reproduktionsevne DK543488A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/103,489 US4975420A (en) 1987-09-30 1987-09-30 Agents and procedures for provoking an immune response to GnRH and immuno sterilizing mammals

Publications (2)

Publication Number Publication Date
DK543488D0 DK543488D0 (da) 1988-09-29
DK543488A true DK543488A (da) 1989-03-31

Family

ID=22295467

Family Applications (1)

Application Number Title Priority Date Filing Date
DK543488A DK543488A (da) 1987-09-30 1988-09-29 Midler til stimulering af et pattedyrs immunreaktion over for gnrh samt et modificeret gnrh og en vaccine til inhibering af et pattedyrs reproduktionsevne

Country Status (12)

Country Link
US (1) US4975420A (da)
EP (1) EP0309863B1 (da)
JP (1) JP2703574B2 (da)
KR (1) KR890004730A (da)
AT (1) ATE74516T1 (da)
AU (1) AU605358B2 (da)
CA (1) CA1335569C (da)
DE (1) DE3869892D1 (da)
DK (1) DK543488A (da)
ES (1) ES2032917T3 (da)
NZ (1) NZ226348A (da)
ZA (1) ZA887304B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8713240D0 (en) * 1987-06-05 1987-07-08 Proteus Biotech Ltd Hormones
JPH0431072Y2 (da) * 1988-03-14 1992-07-27
US5036047A (en) * 1988-09-29 1991-07-30 Pitman-Moore, Inc. Method and composition for preventing conception
US5709879A (en) * 1990-06-29 1998-01-20 Chiron Corporation Vaccine compositions containing liposomes
US5324512A (en) * 1990-12-26 1994-06-28 The Population Council [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses
DE69231232T2 (de) * 1991-03-01 2001-01-04 Merial Lyon Verfahren zur Immunoneutralisierung von nichtkastrierten männlichen Haustieren gegen LMRH und Peptide dafür
AU634379B2 (en) * 1991-04-29 1993-02-18 Csl Limited Recombinant immunocastration vaccine
CA2114125A1 (en) * 1991-07-26 1993-02-18 Wayne G. Reilly Self-adjuvanting peptide vaccine delivery system and production thereof
US5422110A (en) * 1991-10-16 1995-06-06 University Of Saskatchewan Enhanced immunogenicity using leukotoxin chimeras
US5723129A (en) * 1991-10-16 1998-03-03 University Of Saskatchewan GnRH-leukotoxin chimeras
US5837268A (en) * 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
US6797272B1 (en) 1991-10-16 2004-09-28 University Of Saskatchewan Enhanced immunogenicity using leukotoxin chimeras
WO1993008290A1 (en) * 1991-10-16 1993-04-29 University Of Saskatchewan Enhanced immunogenicity using leukotoxin chimeras
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
US5491071A (en) * 1993-08-03 1996-02-13 Abbott Laboratories Reagents and methods for the detection and quantification of testosterone in fluid samples
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
JPH0824828A (ja) * 1994-07-08 1996-01-30 Hiromitsu Uchibori 生ゴミ処理悪臭消化の脱臭剤
US6664369B1 (en) * 1994-08-10 2003-12-16 Creighton University GnRH analogues with antitumour effects and pharmaceutical compositions thereof
AU3361695A (en) * 1994-08-10 1996-03-07 Dezso Gaal Novel gnrh analogues with antitumour effects and pharmaceutical compositions thereof
CA2235510A1 (en) * 1995-10-27 1997-05-01 Merck & Co., Inc. Gnrh/reduced pseudomonas exotoxin conjugates
ATE286511T1 (de) * 1999-02-17 2005-01-15 Pfizer Prod Inc Fusionsproteine mit trägern welche eine doppelte immunantwort induzieren
AU2234801A (en) * 1999-12-13 2002-04-29 Universidad Nacional Autonoma De Mexico Immunoenzymatic quantification method
GB0000891D0 (en) * 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
CL2009000900A1 (es) 2009-04-15 2009-08-14 Univ Chile Proteina de fusion que comprende la hormona liberadora de gonadotrofinas fusionada a una secuencia con capacidad inmunogenica con sitios de o-glicosilacion; secuencia de adn que la codifica; procedimiento de produccion; vacuna que las comprende; y su uso para inmunocastracion de mamiferos.
KR102583484B1 (ko) * 2016-02-01 2023-09-27 엘지전자 주식회사 수위 감지 장치 및 이를 포함하는 의류처리장치의 제어 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302386A (en) * 1978-08-25 1981-11-24 The Ohio State University Antigenic modification of polypeptides
US3963691A (en) * 1974-10-07 1976-06-15 Merck & Co., Inc. Synthetic antigens of luteinizing hormone releasing hormone
US4218439A (en) * 1977-07-14 1980-08-19 The Salk Institute For Biological Studies Peptide which inhibits gonadal function
DE2735515A1 (de) * 1977-08-06 1979-02-22 Hoechst Ag Verwendung von lh-rh-peptiden als antikonzeptive
FR2522967B1 (fr) * 1982-03-15 1986-03-07 Anvar Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant
US4618598A (en) * 1982-04-12 1986-10-21 Duke University Method of regulating hormone function or release
JPH0625068B2 (ja) * 1982-12-10 1994-04-06 シンテツクス（ユ−・エス・エ−・）インコ−ポレイテイド 鼻腔内投与用組成物及びその製造方法
US4676981A (en) * 1984-02-07 1987-06-30 University Of Saskatchewan Monoclonal antibodies against GnRH
US4608251A (en) * 1984-11-09 1986-08-26 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues

Also Published As

Publication number Publication date
AU605358B2 (en) 1991-01-10
EP0309863A2 (de) 1989-04-05
ATE74516T1 (de) 1992-04-15
DE3869892D1 (de) 1992-05-14
KR890004730A (ko) 1989-05-09
DK543488D0 (da) 1988-09-29
NZ226348A (en) 1991-04-26
JP2703574B2 (ja) 1998-01-26
AU2275588A (en) 1989-04-20
CA1335569C (en) 1995-05-16
ZA887304B (en) 1990-06-27
ES2032917T3 (es) 1996-07-16
EP0309863B1 (de) 1992-04-08
US4975420A (en) 1990-12-04
JPH02113A (ja) 1990-01-05
EP0309863A3 (en) 1990-01-10

Similar Documents

Publication Publication Date Title
DK543488A (da) Midler til stimulering af et pattedyrs immunreaktion over for gnrh samt et modificeret gnrh og en vaccine til inhibering af et pattedyrs reproduktionsevne
DK693188A (da) Midler til stimulering af et pattedyrs immunreaktion over for gnrh samt et modificeret gnrh og en vaccine til inhibering af et pattedyrs reproduktionsevne
DE3679708D1 (de) Verfahren zur verleihung von immuntoleranz gegen ein spezifisches antigen.
DK0618813T3 (da) Antigen for M-hybridprotein og bærer for gruppe A streptococcal vaccine
DK0412486T3 (da) Antistoffer mod TNF-bindingsprotein I og F(ab)-fragmenter
ES2013328A6 (es) Un metodo para detectar anticuerpos contra antigenos hiv-1.
DK382989A (da) Cytotoxiske vinca-konjugater bundet til antistoffer og fremgangsmaade til fremstilling deraf
PT87688A (pt) Hybrid protein c and method for its preparation
NO174019C (no) Kjoeretoeyfrontlys og fremgangsmaate for aa frembringe et optisk effektivt system for sammen
ATE101345T1 (de) Selektive entfernung von immunkomplexen.
NO175639C (no) Peptid, antistoff oppnådd ved hjelp av peptidet, en fremgangsmåte for immunologisk bestemmelse av intakt prokollagen peptid (type III) og anvendelse av peptidet
DK0739354T3 (da) Præparater og fremgangsmåder, hvor der anvendes ikke-bundet MPL-receptor til stimulering af blodpladeproduktion
ATE88901T1 (de) Fluorkohlenstoffkette enthaltende antigene konjugate.
DK0383599T3 (da) Protein-anticancermiddel
DE58904672D1 (de) Verfahren zur herstellung einer festphasenmatrix.
ATE109004T1 (de) Toleranzinduktion gegenüber einem fremdantigen.
EP0316818A3 (en) Monoclonal antibodies capable of recognizing n-acetylneuraminic acid in beta-arrangement
DE69014300D1 (de) Radioaktive markierung von proteinen.
NO983220L (no) Sammensetninger og fremgangsmåter for å administrere Borrelia Burgdorferi-antigener
ES8800052A1 (es) Un procedimiento para preparar una proteina de superficie antigenica de anaplasma marginale
ATE175357T1 (de) Empfängnisverhütender impfstoff
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
AU5217890A (en) Monoclonal antibodies in vaccine formulations
ES2074707T3 (es) Anticuerpos monoclonales que distinguen entre proteinas naturales y proteinas con secuencias modificadas.
IT8967056A0 (it) Procedimento di immunizzazione ma gnetica in particolare per mezzi navali

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment